Surgical threads and artificial dura mater, etc.! Medical polymers that can be processed into various shapes.
The "L-lactic acid/ε-caprolactone copolymer (LCL)" is obtained by ring-opening polymerization of L-lactide (the cyclic dimer of lactic acid) and ε-caprolactone as monomers. LCL (75:25) is primarily processed into biodegradable sutures and is available on the market, while LCL (50:50) is used as an artificial dura mater. When used as sutures, the filaments are flexible, allowing even thick filaments to be used as a single monofilament. Our BioDegmer is produced in facilities compliant with ISO 13485, can be processed into a variety of shapes, and is used in a wide range of applications in the medical field. 【Features】 ■ Mainly processed into biodegradable sutures ■ Flexible processing characteristics ■ Capable of being processed into various shapes ■ Properties: Amorphous, flexible *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Specifications (Example)】 Test Items: Standards ■ Polymer Identification: Must match the NMR spectrum of the standard LCL ■ Composition: CLA:CCL = 70:30 − 80:20 (mol%) ■ Molecular Weight (MW): MW = 400,000 − 800,000 ■ Melting Point (Tm): Tm = 150 − 175 (℃) ■ Particle Size: Must not pass through a sieve with an opening of 500 µm * This is the specification (standard) for our representative LCL polymer, LCL (75:25). * For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Applications】 ■Thread (single thread): suturing thread, stent ■Film: adhesion prevention membrane, artificial dura mater ■Membrane: periodontal tissue regeneration membrane, artificial dura mater, adhesion prevention membrane, scaffold ■Sol: adhesive *For more details, please refer to the PDF document or feel free to contact us.
catalog（2）
Download All Catalogs
Company information
BMG is a research and development venture company that has been challenging the development of new biomaterial products adapted to trends in the medical field, based on a long-standing strong collaboration with the Kyoto University Institute for Advanced Medical Research. Focusing on the field of medical polymers (macromolecules), we are engaged in two promising growth businesses: the "BioDegmer" business and the new products business, as well as research and development aimed at providing innovative solutions in the medical field. Under the management philosophy of "contributing to the health of people around the world by working on the development of better biomaterial products and providing innovative solutions in the medical field," we support the improvement of technologies in the next generation of regenerative medicine and the healthy well-being of people in three areas.